UNIPHAR PLC EO -08
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more
Market Cap & Net Worth: UNIPHAR PLC EO -08 (0NR)
UNIPHAR PLC EO -08 (F:0NR) has a market capitalization of $1.06 Billion (€1.04 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #7492 globally and #794 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying UNIPHAR PLC EO -08's stock price €4.00 by its total outstanding shares 259574298 (259.57 Million).
UNIPHAR PLC EO -08 Market Cap History: 2019 to 2026
UNIPHAR PLC EO -08's market capitalization history from 2019 to 2026. Data shows growth from $307.21 Million to $1.06 Billion (21.90% CAGR).
UNIPHAR PLC EO -08 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how UNIPHAR PLC EO -08's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0NR by Market Capitalization
Companies near UNIPHAR PLC EO -08 in the global market cap rankings as of March 18, 2026.
Key companies related to UNIPHAR PLC EO -08 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
UNIPHAR PLC EO -08 Historical Marketcap From 2019 to 2026
Between 2019 and today, UNIPHAR PLC EO -08's market cap moved from $307.21 Million to $ 1.06 Billion, with a yearly change of 21.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.06 Billion | +19.43% |
| 2025 | €891.26 Million | +66.00% |
| 2024 | €536.89 Million | -23.12% |
| 2023 | €698.30 Million | -11.57% |
| 2022 | €789.69 Million | -38.89% |
| 2021 | €1.29 Billion | +103.75% |
| 2020 | €634.22 Million | +106.44% |
| 2019 | €307.21 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of UNIPHAR PLC EO -08 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Billion USD |
| MoneyControl | $1.06 Billion USD |
| MarketWatch | $1.06 Billion USD |
| marketcap.company | $1.06 Billion USD |
| Reuters | $1.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.